El impulso a las renovables y la restricción del gas sufrida con motivo de la guerra de Ucrania han acelerado la transición a otro tipo de combustibles o energías. Una de esas alternativas es el hidrógeno, que podemos usar bien como combustible directamente o como forma d …
Draeger contacted customers last month after receiving reports that devices stopped providing ventilation because of depleted batteries.
Problem with Draeger transport ventilators categorized as Class I recall by FDA Read More »
The City of Hope’s highly anticipated Spirit of Life Celebration gala honoring Dr. Farouk Shami, chairman and founder of Farouk Systems, Inc., invited hundreds of esteemed beauty industry leaders to an enchanting evening of philanthropy, entertainment, and inspiration.
NovaBay ® Pharmaceuticals, Inc . announces that sales of Avenova ® -branded products reached a new record during the Amazon Prime Day event held July 11-12, 2023, with sales increasing 22% over Prime Day 2022 and 43% over Prime Day 2021.
NovaBay Pharmaceuticals Reports Record Avenova Sales Day Read More »
KalVista Pharmaceuticals, Inc. announced the acceptance of multiple abstracts at the 2023 US HAEA National Summit taking place in Orlando, Florida from July 20-23.
Korro Bio, Inc. and Frequency Therapeutics, Inc. announced that they have entered into a definitive merger agreement to combine the companies in an all-stock transaction.
Korro Bio and Frequency Therapeutics Announce Merger Agreement Read More »
La elección de seguir una dieta basada en plantas es una decisión personal que cada vez más personas están considerando. Sin embargo, existe un debate en curso sobre cuál es la mejor opción: ¿la dieta vegetariana o la dieta vegana? Examinemos los aspe …
RaySearch Laboratories AB announces the release of the latest version of RayCare®*, the next generation oncology information system.
Sales of SEK 905 (829) million, an increase of 9%, or 10% excluding discontinued business. In local currencies the growth was 3% and excluding discontinued business 4%.
Interim report Q2, 2023: Strong growth in APAC – Vitrolife AB (publ) Read More »
InnoCare Pharma and ArriVent Biopharma announced a clinical development collaboration to evaluate the combination of InnoCare’s novel SHP2 allosteric inhibitor, ICP-189, with ArriVent’s furmonertinib, a highly brain-penetrant, broadly active mutation-selective EGFR inhibitor.
InnoCare and ArriVent Announce Clinical Development Collaboratio Read More »
